Ingredion Incorporated $INGR Shares Bought by American Century Companies Inc.

Key Points

• American Century Companies Inc. increased its stake in Ingredion Incorporated by 53.0%, owning 248,333 shares worth approximately $33.58 million.
• Ingredion reported a quarterly earnings result of $2.87 earnings per share, exceeding analysts' expectations, though revenue fell short at $1.83 billion, down 2.4% year-over-year.
• Recent analyst ratings show a downgrade from "strong-buy" to "buy" by Wall Street Zen, with a consensus rating of "Hold" and an average target price of $151.40.

American Century Companies Inc. raised its stake in Ingredion Incorporated (NYSE:INGR - Free Report) by 53.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 248,333 shares of the company's stock after acquiring an additional 86,055 shares during the period. American Century Companies Inc. owned 0.39% of Ingredion worth $33,577,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also made changes to their positions in the company. Mariner LLC lifted its holdings in shares of Ingredion by 19.3% in the 4th quarter. Mariner LLC now owns 15,980 shares of the company's stock valued at $2,198,000 after purchasing an additional 2,583 shares during the last quarter. NewEdge Advisors LLC lifted its holdings in shares of Ingredion by 7.4% in the 4th quarter. NewEdge Advisors LLC now owns 8,890 shares of the company's stock valued at $1,223,000 after purchasing an additional 610 shares during the last quarter. MetLife Investment Management LLC lifted its holdings in shares of Ingredion by 9.2% in the 4th quarter. MetLife Investment Management LLC now owns 36,737 shares of the company's stock valued at $5,054,000 after purchasing an additional 3,101 shares during the last quarter. Tower Research Capital LLC TRC lifted its holdings in shares of Ingredion by 405.1% in the 4th quarter. Tower Research Capital LLC TRC now owns 6,258 shares of the company's stock valued at $861,000 after purchasing an additional 5,019 shares during the last quarter. Finally, Pinebridge Investments L.P. raised its holdings in shares of Ingredion by 27.7% in the fourth quarter. Pinebridge Investments L.P. now owns 37,511 shares of the company's stock valued at $5,160,000 after buying an additional 8,131 shares during the last quarter. Institutional investors and hedge funds own 85.27% of the company's stock.

Insider Buying and Selling

In other Ingredion news, CEO James P. Zallie sold 36,287 shares of the stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of $126.52, for a total transaction of $4,591,031.24. Following the transaction, the chief executive officer owned 50,129 shares of the company's stock, valued at $6,342,321.08. This represents a 41.99% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Larry Fernandes sold 850 shares of the firm's stock in a transaction on Monday, August 4th. The stock was sold at an average price of $128.39, for a total value of $109,131.50. Following the sale, the senior vice president owned 31,171 shares in the company, valued at $4,002,044.69. This trade represents a 2.65% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 37,137 shares of company stock valued at $4,700,163. Company insiders own 1.80% of the company's stock.

Analyst Ratings Changes

Several research analysts have weighed in on the company. Wall Street Zen downgraded Ingredion from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 9th. UBS Group boosted their target price on Ingredion from $149.00 to $151.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 9th. Two research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $151.40.

Ingredion Price Performance

Shares of INGR stock traded up $1.4480 during trading hours on Friday, hitting $129.0880. The company's stock had a trading volume of 388,783 shares, compared to its average volume of 452,475. The business has a fifty day moving average of $132.58 and a 200-day moving average of $132.78. The stock has a market cap of $8.28 billion, a price-to-earnings ratio of 12.59, a P/E/G ratio of 1.03 and a beta of 0.71. Ingredion Incorporated has a twelve month low of $120.51 and a twelve month high of $155.44. The company has a current ratio of 2.78, a quick ratio of 1.81 and a debt-to-equity ratio of 0.41.

Ingredion (NYSE:INGR - Get Free Report) last announced its earnings results on Friday, August 1st. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.78 by $0.09. The firm had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.89 billion. Ingredion had a net margin of 9.24% and a return on equity of 19.04%. The firm's revenue for the quarter was down 2.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.87 EPS. Ingredion has set its FY 2025 guidance at 11.100-11.600 EPS. As a group, equities research analysts anticipate that Ingredion Incorporated will post 11.14 EPS for the current year.

Ingredion Profile

Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.